CN100413969C - Chimeric gene with delta 6 fatty acid dehydrogenase function and its use - Google Patents
Chimeric gene with delta 6 fatty acid dehydrogenase function and its use Download PDFInfo
- Publication number
- CN100413969C CN100413969C CNB2005100116085A CN200510011608A CN100413969C CN 100413969 C CN100413969 C CN 100413969C CN B2005100116085 A CNB2005100116085 A CN B2005100116085A CN 200510011608 A CN200510011608 A CN 200510011608A CN 100413969 C CN100413969 C CN 100413969C
- Authority
- CN
- China
- Prior art keywords
- leu
- phe
- expression vector
- plant
- yeast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 54
- 239000000194 fatty acid Substances 0.000 title abstract description 21
- 235000014113 dietary fatty acids Nutrition 0.000 title abstract description 17
- 229930195729 fatty acid Natural products 0.000 title abstract description 17
- 150000004665 fatty acids Chemical class 0.000 title abstract description 16
- 101710088194 Dehydrogenase Proteins 0.000 title abstract description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 42
- 241000196324 Embryophyta Species 0.000 claims abstract description 35
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims abstract description 30
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims abstract description 30
- 230000014509 gene expression Effects 0.000 claims abstract description 29
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 31
- 229960002733 gamolenic acid Drugs 0.000 claims description 27
- 239000013604 expression vector Substances 0.000 claims description 22
- 210000004027 cell Anatomy 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 239000002773 nucleotide Substances 0.000 claims description 9
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 239000013612 plasmid Substances 0.000 claims description 8
- 229920001184 polypeptide Polymers 0.000 claims description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- 210000005253 yeast cell Anatomy 0.000 claims description 6
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 5
- 240000003768 Solanum lycopersicum Species 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 244000061176 Nicotiana tabacum Species 0.000 claims description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 4
- 102000007469 Actins Human genes 0.000 claims description 3
- 108010085238 Actins Proteins 0.000 claims description 3
- 235000013311 vegetables Nutrition 0.000 claims description 3
- 244000105624 Arachis hypogaea Species 0.000 claims description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 claims description 2
- 244000020551 Helianthus annuus Species 0.000 claims description 2
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 2
- 241000209510 Liliopsida Species 0.000 claims description 2
- 240000000528 Ricinus communis Species 0.000 claims description 2
- 235000004443 Ricinus communis Nutrition 0.000 claims description 2
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 2
- 244000000231 Sesamum indicum Species 0.000 claims description 2
- 238000004520 electroporation Methods 0.000 claims description 2
- 230000000763 evoking effect Effects 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 238000000520 microinjection Methods 0.000 claims description 2
- 235000020232 peanut Nutrition 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- 239000013603 viral vector Substances 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 235000017060 Arachis glabrata Nutrition 0.000 claims 1
- 235000010777 Arachis hypogaea Nutrition 0.000 claims 1
- 235000018262 Arachis monticola Nutrition 0.000 claims 1
- 102400000757 Ubiquitin Human genes 0.000 claims 1
- 108090000848 Ubiquitin Proteins 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract description 20
- 239000000758 substrate Substances 0.000 abstract description 15
- 235000001466 Ribes nigrum Nutrition 0.000 abstract description 14
- 241001312569 Ribes nigrum Species 0.000 abstract description 14
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 abstract description 14
- 238000000855 fermentation Methods 0.000 abstract description 2
- 230000004151 fermentation Effects 0.000 abstract description 2
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 229940098330 gamma linoleic acid Drugs 0.000 abstract 3
- 235000020778 linoleic acid Nutrition 0.000 abstract 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 27
- 108020004414 DNA Proteins 0.000 description 21
- 229960004232 linoleic acid Drugs 0.000 description 19
- 239000012634 fragment Substances 0.000 description 16
- 239000002253 acid Substances 0.000 description 13
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000013613 expression plasmid Substances 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 7
- 238000001819 mass spectrum Methods 0.000 description 7
- 235000007689 Borago officinalis Nutrition 0.000 description 6
- 240000004355 Borago officinalis Species 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 238000013467 fragmentation Methods 0.000 description 5
- 238000006062 fragmentation reaction Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 102220023257 rs387907546 Human genes 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000196929 Oenothera glazioviana Species 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 101100008162 Candida tropicalis Cytb5 gene Proteins 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000219960 Oenothera sp. Species 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical class CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 102220369445 c.668T>C Human genes 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 102220004457 rs11567847 Human genes 0.000 description 2
- 102220023258 rs387907548 Human genes 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000722877 Borago Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 241001575980 Mendoza Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 241001505297 Pythium irregulare Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000005477 standard model Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000006200 vaporizer Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
In the present invention, one segment RnD6A which is from ribes nigrum L. DNA and other two segments of RnD6A and RnD6B of about 208 bp are used for respectively constructing two chimeric genes of RnD6CA and RnD6CB with complete reading frames, and the RnD6CA and RnD6CB are expressed in a yeast expression system, GC-MS analysis indicates that protein coded in the two chimeric genes in yeast can catalyze external substrate linoleic acid to generate gamma-linoleic acid, and the gamma-linoleic acid has the function of delta <6> fatty acid dehydrogenase. The present invention can be used for adopting a genetic engineering technique to produce the gamma-linoleic acid by a yeast fermentation system and a plant expression system.
Description
Technical field
The present invention relates to plant code gene and application thereof.Particularly, relate to two mosaic gene RnD6CA and RnD6CB with entire reading frame frame, its respectively the origin three segment DNA sequence constructs that come from blackcurrant (Ribesnigrum L.) form.The invention still further relates to this mosaic gene coded have a Δ
6The polypeptide of fatty acid dehydrogenase function, and contain the Yeast expression carrier of this dna sequence dna and plant expression vector, host cell, and utilize the application of transformed yeast and plant production gamma-linolenic acid respectively of this gene.
Background technology
In the fatty acid metabolism process, Δ
6Fatty acid dehydrogenase (Δ
6-fatty aciddesaturase, D6D) catalysis linolic acid (linoleic acid, LA, 18:2 Δ
9,12) the 6th carbon atom dehydrogenation form gamma-linolenic acid (γ-linolenic acid, GLA, 18:3/ Δ 6,9,12) [1].Gamma-linolenic acid can further form arachidonic acid, Prostaglandins and Leukotrienes class physiologically active substance by carbochain prolongation and dehydrogenation again, and these products produce material impact in a series of physiological functions such as brain development, vision, anaphylaxis and cardiovascular motion of people.
As a kind of essential unsaturated fatty acids of human body, gamma-linolenic acid has reducing blood-fat, anti peroxidation of lipid, fat-reducing, inhibition ulcer, strengthens a series of biological functions [1,2] such as Regular Insulin, antithrombotic cardiovascular disorder human body.At present, gamma-linolenic acid has been used as a kind of new VITAMIN-vitamin F and has been studied utilization [3] in the world.Thereby, in producing as gamma-linolenic acid key enzyme---Δ 6 fatty acid dehydrogenases are also also more and more studied and are utilized.Up to now, the clone's acquisition from animal [4], plant [5], fungi [6] and nematode different biologies such as [7] of Δ 6 fatty acid dehydrogenase genes, and yeast saccharomyces cerevisiae [7,8], tomato [9], tobacco [5,10], successfully obtained expression in rape [6,8] and the soybean [11] etc.
In plant, only a few plants such as root of Redsepal Eveningprimrose (Oenothera sp.), Borrago officinalis (Borago officinalisL.) and blackcurrant contain GLA[12], the existing abroad research report of Δ 6 fatty acid dehydrogenase genes of Borrago officinalis [5] and root of Redsepal Eveningprimrose [13], and two fusion genes that this patent relates to are the reported first that derive from Δ 6 fatty acid dehydrogenase genes of blackcurrant.
Because what this genoid was coded is an albumen, can adopt the yeast saccharomyces cerevisiae expression system to carry out vivoexpression, but owing to this albumen is positioned on chloroplast(id) or the endoplasmic reticulum, and be a membranin, even in the vivoexpression system, express, also more difficult separation and purification.So general the employing investigated expressed albumen the method for the catalytic activity that adds substrate carried out Function Identification.
In the yeast saccharomyces cerevisiae expression system that is adopted, recipient bacterium is uridylic defective type INVSc I, itself do not contain LA (linolic acid) and GLA (gamma-linolenic acid), therefore, adding under the linoleic condition of substrate, if in Yeast engineering bacteria, detect the catalysate gamma-linolenic acid, just can determine that the coded albumen of foreign gene has obtained expression in yeast expression system, produced katalysis to adding substrate.So yeast saccharomyces cerevisiae is as the most frequently used, the effectively expressing system of Δ 6, the functional evaluation of Δ 12-fatty acid dehydrogenase gene of research external source, and existing many successful researchs reports [5,6,7].The detection of lipid acid mainly adopts GC/MS (gas-chromatography-matter coupling technique) to finish.Its principle is by GC (gas-chromatography) different fatty acid components to be separated, and respectively every kind of component is carried out the mass spectrometry analysis by MS (mass spectrum) detector then, thus the coupling analytical technology of the comparative maturity of the composition of definite each component and content.
In the plant, GLA exists only in a few plants such as root of Redsepal Eveningprimrose (Oenothera sp.), Borrago officinalis (Boragoofficinalis L.) and blackcurrant [12], and the seed oil production of these plants also becomes at present the primary commercial source of GLA in the world.Utilize the produce oil fungi fermentation also can extract and obtain GLA, but the GLA output that obtains by existing these modes of production is all very low, can not satisfy the growing market requirement [13] far away.Therefore, utilize yeast saccharomyces cerevisiae or transgenosis oil plant crop plant to express the external source Δ
6Fatty acid dehydrogenase is produced gamma-linolenic acid and is had important Research Significance and economic worth.
Summary of the invention
The invention provides two mosaic gene RnD6CA and RnD6CB, its nucleotide sequence is respectively shown in SEQ ID NO:1 and SEQ ID NO:2, these two mosaic genes are dna fragmentation RnD6C and the RnD6A that are used to come from blackcurrant (Ribes nigrum L.), reach RnD6C and RnD6B structure and form, encoded polypeptide is respectively shown in SEQ ID NO:6 and SEQ ID NO:7 (Fig. 6 and 7).
The invention provides three dna fragmentation RnD6C, RnD6A, RnD6B that derive from blackcurrant (Ribes nigrum L.), its nucleotide sequence is respectively shown in SEQ ID NO:3, SEQ IDNO:4 and SEQ ID NO:5.
Another object of the present invention provides the Yeast expression carrier that contains mosaic gene RnD6CA, RnD6CB, and utilizes this expression vector transformed yeast cells.Polypeptide expressed in transformed yeast cells has Δ
6Fatty acid dehydrogenase function can catalysis add substrate linolic acid generation gamma-linolenic acid.
Another purpose of the present invention provides a kind of plant expression vector that contains mosaic gene RnD6CA, RnD6CB.Can use any expression vector that can guide foreign gene in plant, to express.These plant expression vectors include but not limited to: the double base agrobacterium vector, and pBIN19 for example, pBI121, pB221 contains the evoked promoter of DRE and/or ABRE element and the plant expression vector that is used for the monocotyledons micropellet bombardment.
Carrier of the present invention also can contain suitable promotor.Can use any strong promoter in the present invention.These promotors include but not limited to cauliflower mosaic virus (CaMV 35S), Ubiqutin, Actin etc. and plant tissue position specific expression promoter etc.It can use separately or be used in combination with other plant promoter.
Expression vector of the present invention can be by the use Ti-plasmids, the Ri plasmid, and plant viral vector, directly DNA transforms, microinjection, modes such as electroporation import vegetable cell.
Can be used for plant transformed host of the present invention and be dicotyledons, described dicotyledons is selected from the group of being made up of plants such as tobacco, rape, Sunflower Receptacle, soybean, tomato, castor-oil plant, sesame and peanuts.
The invention still further relates to mosaic gene RnD6CA, the RnD6CB application in producing gamma-linolenic acid.
Description of drawings:
Fig. 1. the nucleotide sequence of mosaic gene RnD6CA, SEQ ID NO:1.
Fig. 2. the nucleotide sequence of mosaic gene RnD6CB, SEQ ID NO:2.
The segmental nucleotide sequence of Fig. 3 .RnD6A, SEQ ID NO:3.
The segmental nucleotide sequence of Fig. 4 .RnD6B, SEQ ID NO:4.
The segmental nucleotide sequence of Fig. 5 .RnD6C, SEQ ID NO:5.
Fig. 6. mosaic gene RnD6CA encoded polypeptide, SEQ ID NO:6, wherein line part is respectively Cytb5 functional domain and three His Box functional domains.
Fig. 7. mosaic gene RnD6CB encoded polypeptide, SEQ ID NO:7, wherein line part is respectively Cytb5 functional domain and three His Box functional domains.
Fig. 8. the Yeast expression carrier figure of mosaic gene RnD6CA/B.
Fig. 9. the plant expression vector figure of mosaic gene RnD6CB/B.
Figure 10. the total fatty acids GC-MS that mosaic gene RnD6CA/B expresses in yeast saccharomyces cerevisiae analyzes
A) GC-MS of INVSc I yeast strain lipid acid composition;
B) GC-MS of LA (linolic acid), GLA (gamma-linolenic acid) standard model is formed and be added with to INVSc I yeast strain lipid acid;
C) contain unloaded pYES2 expression plasmid zymic total fatty acids GC-MS;
D) contain the total fatty acids GC-MS of unloaded pYES2 expression plasmid yeast after adding the LA substrate for induction;
E) the total fatty acids GC-MS of yeast saccharomyces cerevisiae after adding the LA substrate for induction of expression RnD6CA gene, the red arrow indication is the product peak;
F) product peak partial enlarged drawing (X10);
G) the total fatty acids GC-MS behind the yeast saccharomyces cerevisiae interpolation LA substrate for induction of expression RnD6CB gene, the arrow indication is the product peak.
Figure 11. MS collection of illustrative plates during RnD6CA/B genetic expression catalysate GC-MS analyzes in the yeast saccharomyces cerevisiae, the MS figure of the yeast expression catalysate of a:RnD6CA/B; B: the MS figure of gamma-linolenic acid standard substance.
Embodiment
Describe the present invention in detail below with reference to embodiment and accompanying drawing.What those having ordinary skill in the art will appreciate that is, following embodiment is illustrational purpose, and it should not be interpreted as limitation of the present invention by any way.Protection scope of the present invention is limited by accompanying Claim.
The structure of embodiment 1. mosaic genes
1. the preparation of blackcurrant genomic dna
With blackcurrant (Ribes nigrum L.) the live body plant planted in the Beijing Botanical Garden is material, get its young tender leaf agreement that contracts a film or TV play to an actor or actress 100mg, in 7mL Ep pipe, add steel ball (diameter 5mm), place the freezing 20-30min of liquid nitrogen, high-speed breakage on the whirlpool device, repeatable operation 2-3 time, broken fully to material.The CTAB extract of adding 1-2mL preheating (referring to " fine works molecular biology experiment guide " 2001, Science Press, Yan Ziying, Wang Hailin is translated).Mixing.65 ℃ of water-bath 30min.Add the equal-volume chloroform, the soft about 5min of extracting.In the centrifugal 10min of 12000rpm room temperature.Get supernatant, add 1/2 volume Virahol mixing, room temperature is placed 10min deposit D NA.With the Tip head DNA that is settled out is chosen, with washed twice in 70% ethanol, room temperature is placed 30min in 70% ethanol.Remove 70% ethanol, dry up in the air.Be dissolved in an amount of sterilization ddH
2O ,-20 ℃ of preservations.
2.RnD6A, the clone of RnD6B, RnD6C dna fragmentation
The design primer is cloned RnD6A, RnD6B, RnD6CDNA fragment (Fig. 3,4 and 5) respectively from the DNA that extract the front.Used reaction system is as follows:
PCR reaction system (50ul):
(RnD6A, RnD6B, three segmental sizes of purpose of RnD6C are respectively 0.22kb to cut glue recovery purpose fragment behind the PCR product electrophoresis (1% gel strength), 0.22kb and 1.1kb), be connected into pMD18-T carrier (Takara Biotech. (Dalian) Co.Ltd) sequence verification.
The primer is as follows respectively:
1) the segmental clone's the primer of .RnD6ADNA
Forward primer: 5 '-TTGAGCATCATTTGTTCCCTCGATTGCCTCGATGCC-3 ' (SEQ ID NO:8)
Reverse primer: Xba I
5′-GCGG
TCTAGATCACCCCGGGCAGGTGACAGCTT-3′(SEQ?IDNO:9)
2) clone's the primer of .RnD6B dna fragmentation
Forward primer: 5 '-TTGAGCATCATTTGTTCCCAAGATTGCCTCGATGCC-3 ' (SEQ ID NO:10)
Reverse primer: Xba I
5′-GCGG
TCTAGATCAGCCATAGGTGTTGACAGCTTCCC-3′(SEQID?NO:11)
3) clone's the primer of .RnD6C dna fragmentation
Forward primer: Hind III
5′-CGCG
AAGCTTATGGCTAATGCAATCAAGAAGTACATG-3′(SEQ?ID?NO:12)
Reverse primer: 5 '-GGGAACAAATGATGCTCAATTTGG-3 ' (SEQ ID NO:13)
3. the structure of mosaic gene RnD6CA and RnD6CB
RnD6A, RnD6B, RnD6C fragment that be cloned into and sequence verification are template above utilizing, utilize round pcr to obtain mosaic gene RnD6CA and RnD6CB sequence, and, be connected into pMD18-T in two ends introducing HindIII and XbaI enzyme cutting site, pass through sequence verification.
Concrete operations are as follows:
1). the used RnD6A of preparation mosaic gene, RnD6B, RnD6C fragment
The 2nd identical PCR reaction system of joint and PCR program among the embodiment 1 obtains RnD6A, RnD6B, RnD6C fragment respectively above utilizing, and reclaims by gel electrophoresis (1% gel strength).
Wherein:
The RnD6A fragment utilizes that primer sequence obtains by pcr amplification shown in SEQ ID NO:8 and the SEQ ID NO:9;
The RnD6B fragment utilizes that primer sequence obtains by pcr amplification shown in SEQ ID NO:10 and the SEQ ID NO:11;
The RnD6C fragment utilizes that primer sequence obtains by pcr amplification shown in SEQ ID NO:12 and the SEQ ID NO:13.
2) mosaic gene preparation
A) preparation of RnD6CA mosaic gene
RnD6A (fragment 1) and RnD6C (fragment 2) fragment are merged formation RnD6CA mosaic gene (Fig. 1).The primer sequence is:
Forward primer: Hind III
5′-CGCG
AAGCTTATGGCTAATGCAATCAAGAAGTACATG-3′(SEQ?IDNO:12)
Reverse primer: Xba I
5′-GCGG
TCTAGATCACCCCGGGCAGGTGACAGCTT-3′(SEQ?ID?NO:9)
B) preparation of RnD6CB mosaic gene
RnD6B (fragment 1) and RnD6C (fragment 2) fragment are merged formation RnD6CB mosaic gene (Fig. 2).The primer sequence is:
Forward primer: Hind III
5′-CGCG
AAGCTTATGGCTAATGCAATCAAGAAGTACATG-3′(SEQ?IDNO:12)
Reverse primer: Xba I
5′-GCGG
TCTAGATCAGCCATAGGTGTTGACAGCTTCCC-3′(SEQ?IDNO:11)
The PCR reaction system is carried out the PCR fusion below utilizing, to obtain mosaic gene:
Merge PCR reaction system (20ul):
Total length mosaic gene PCR reaction system (50ul):
Cutting glue behind the PCR product electrophoresis reclaims, obtain RnD6CA and RnD6CB mosaic gene full length fragment (about 1.3Kb) respectively, (left end has the HindIII restriction enzyme site to be connected into the pMD18-T carrier, right-hand member has the BamHI restriction enzyme site), transformed into escherichia coli DH-5 α (concrete source please be provided) preserves, simultaneously sequence verification.
The structure of embodiment 2. mosaic gene yeast vectors
From the pMD18-T carrier that contains mosaic gene RnD6CA and RnD6CB, utilize HindIII and XbaI enzyme cutting site, two enzyme enzymes are cut the back and are obtained RnD6CA and RnD6CB gene, directed cloning is in Yeast expression carrier pYES2.0 (available from Invitrogen company), obtain expression plasmid of yeast pYRnD6CA and pYRnD6CB, transformed into escherichia coli DH-5 α preserves.Its carrier collection of illustrative plates is seen Fig. 8.
The expression of embodiment 3. mosaic genes in yeast
1. zymic transforms
With reference to the described method of the pYES2Kit of Invitrogen company (Cat#V285-20), expression plasmid of yeast pYRnD6CA and pYRnD6CB (plasmid figure is referring to Fig. 8) with above-mentioned mosaic gene, adopt Lithium Acetate mediated transformation yeast saccharomyces cerevisiae auxotrophic strain INVSc I (with reference to the described method for transformation of the pYES2Kit of Invitrogen company) (purchasing company) in Invitrogen, with empty carrier pYES2.0 plasmid is contrast, obtains to contain the yeast cell of each expression plasmid.
2. the abduction delivering of yeast conversion cell
Get and contain the yeast list bacterium colony that the mosaic gene expression plasmid of yeast transforms, be inoculated in 50ml and contain in the SC-U nutrient solution of 2% silk floss sugar (with reference to the described prescription of the pYES2Kit of Invitrogen company) 250rpm on shaking table, 28 ℃ of overnight incubation.Add Nuo Nade P-40 (NP-40 then, available from BBI company) (final concentration 1%), external source linolic acid substrate (available from Sigma company) (final concentration is 0.003%), and yeast expression inductor D-semi-lactosi (available from Amresco company) (final concentration is 2%) 250rpm, cultivate the 48h abduction delivering for 22 ℃.
Embodiment 4. mosaic gene yeast expression products are to Δ
6The GC-MS of fatty acid dehydrogenase substrate catalysate analyzes
1. the extraction of lipid acid and esterification.
Yeast thalline after centrifugal collection is got and induced, deionized water wash, 50 ℃ of oven dry.Get 0.1g yeast powder (in example 3.2, induce obtained yeast promptly) and fully grind, add 5ml 5%KOH-CH through 50 ℃ of oven dry
3OH (available from Aldtich company), behind 70 ℃ of water-bath 5h, adding HCl is acidified to its pH value and reaches 2.0.Add 4ml 14%BF again
3-CH
3OH (available from Aldtich company) solution, 70 ℃ of water-bath 1.5h.Add 2ml 0.9%NaCl solution, static a moment behind the mixing.Add the 2ml chloroform again: normal hexane (V/V 1: 4) extracting, draw extract, N
2Dry up.Be dissolved in 100 μ l ethyl acetate at last.
2. end product GC-MS check and analysis experiment.
Used GC/MS instrument is TurboMass (a PerkinElmer company), pillar: BPX-70,30m * 0.25mm * 0.25vm, 120 ℃ of column temperatures, 230 ℃ of vaporizer temperature.Get sample on the 1 μ l end product, splitting ratio 10: 1.
3.GC-MS interpretation of result
Comparison diagram 10a, 10b and 10c, show and do not adding under the linolic acid substrate condition, used yeast engineering strain and contain and new product peak do not occur occur in the unloaded pYES2 expression plasmid of inductive yeast illustrates not contain in used yeast engineering strain and the unloaded pYES2 expression plasmid zymic total fatty acids to add substrate linolic acid (LA) and catalysate gamma-linolenic acid (GLA).
When adding the linolic acid substrate, and when carrying out abduction delivering, contrast (unloaded pYES2.O) does not also have the appearance (referring to Figure 10 d) of product peak gamma-linolenic acid (GLA).And after the yeast expression bacterium of pYRnD6CA/B induced, add substrate linolic acid (LA) and can be generated gamma-linolenic acid (GLA) (referring to Figure 10 e and 10g) by catalysis
Comparison diagram 10e, 10f and 10g can find when retention time is 7.6 minutes, have a new material to generate., its appearance time and peak figure and the mass spectrum consistent (referring to Figure 11 a and 11b) of mass spectrum with standard substance gamma-linolenic acid (available from Sigma company) are defined as gamma-linolenic acid.
Above result's proof derives from two mosaic gene RnD6CA/B successful expression in yeast saccharomyces cerevisiae of blackcurrant, and expressed albumen can catalysis add substrate linolic acid (LA) generation gamma-linolenic acid (GLA).
The structure of embodiment 5. mosaic gene RnD6CA/B plant expression vectors
The structure of the plant expression vector of RnD6CA/B molecular biology method routinely carries out (referring to " fine works molecular biology experiment guide " 2001, Science Press, Yan Ziying, Wang Hailin is translated).With RnD6CA/B DNA is template, introduce Sac I site (Xba I is changed to Sac I site) in BamHI site (Hind III is changed to BamH I site) and the reverse primer (SEQ ID NO:9 (RnD6CA) and SEQ ID NO:11 (RnD6CB)) by in forward primer (SEQ ID NO:12), introducing, be inserted into the CaMV 35S promoter back in the pBI121 binary expression vector [14], obtain a binary expression vector pRnD6CA/B, its collection of illustrative plates as shown in Figure 9.Through BamH I and SacI enzyme cut, PCR identify to insert fragment errorless after, change Agrobacterium LBA4404[15 over to], through extracting plasmid, enzyme is cut, PCR confirms.This expression vector can be directly used in the conversion (referring to Fig. 9) of plant.
Reference:
1.Gunstone?FD(1992)Gamma?linolenic?acid-occurrence?and?physicaland?chemical?properties.Prog?Lipid?Res?31:145-161.
2.Horrobin?DF(1992)Nutritional?and?medical?importance?ofgamma-linolenic?acid.Prog?Lipid?Res?31:163-194.
3.Huang?Y-S,Milles?DE(1996)Gamma-Linolenic?Acid:Metabolismand?Its?Roles?in?Nutrition?and?Medicine.AOCS?Press,Champaign,IL.
4.Hyekyung?P.Cho,Manabu?T.Nakamura,and?Steven?D.Clarke(1999)Cloning,Expression,and?Nutritional?Regulation?of?the?MammalianΔ
6-Desaturase.JBC?274(1):471-477.
5.Sayanova?O,Smith?MA,Lapinskas?P,Stobart?AK,Dobson?G,ChristieWW,Shewry?PR,Napier?JA(1997)Expression?of?a?borage?desaturasecDNA?containing?an?N-terminal?cytochrome?b5?domain?results?in?theaccumulation?of?high?levels?ofΔ
6-desaturated?fatty?acids?in?transgenictobacco.PNAs?94:4211-4216.
6.Haiping?Hong,Nagamani?Datla,Darwin?W.Reed,Patrick?S.Covello,Samuel?L.MacKenzie,and?Xiao?Qiu(2002)High-Level?Production?ofγ-Linolenic?Acid?in?Brassica?juncea?Using?aΔ
6Desaturase?from?Pythiumirregulare.Plant?Physiology?129:354-362.
7.Napier?JA,Hey?SJ,Lacey?DJ,Shewry?PR(1998)Identification?of?aCaenorhabditis?elegans?Δ
6-fatty-acid-desaturase?by?heterologousexpression?in?Saccharomyces?cerevisiae.Biochem?J?330:611-614.
8.Qiu?X,Hong?HP,Datla?N,MacKenzie?SL,Tayler?CD,Thomas?LT(2002)Expression?of?borageΔ
6-desaturase?in?Saccharomyces?cerevisiaeand?oilseed?crops.Can?J?Bot?80:42-49.
9.Cook?D,Grierson?D,Jones?C,Wallace?A,West?G,Tucker?G(2002)Modification?of?fatty?acid?composition?in?tomato(Lycopersiconesculentum)by?expression?of?a?borageΔ
6-desaturase.Mol?Biotechnol.21(2):123-128.
10.Olga?Sayanova,Mark?A.Smith,Peter?Lapinskas,A.Keith?Stobart,Gary?Dobson,William?W.Christie,Peter?R.Shewry,And?Johnathan?A.Napier(1997)Expression?of?a?borage?desaturase?cDNA?containing?anN-terminal?cytochrome?b5?domain?results?in?the?accumulation?of?highlevels?of?Δ
6-desaturated?fatty?acids?in?transgenic?tobacco.PNAs94:4211-4216.
11.Shirley?Sato,Aiqiu?Xing,Xingguo?Ye,Bruce?Schweiger,AnthonyKinney,George?Graef?and?Tom?Clemente(2004)Production?of?γ-LinolenicAcid?and?Stearidonic?Acid?in?Seeds?of?Marker-Free?Transgenic?Soybean.Genomics?Molecular?Genetics?&?Biotechology?44:646-652.
12.Ucciani?E(1995)Nouveau?Dictionnaire?des?Huiles?Végétales-Composition?en?Acides?Gras.Lavoisier,Paris?pp?3-596.
13.Emilio?Mendoza?de?Gyves,Caroline?A.Sparks,Olga?Sayanova,PaulLazzeri,Johnathan?A.Napier?and?Huw?D.Jones(2004)Geneticmanipulation?of?γ-linolenic?acid(GLA)synthesis?in?a?commercial?varietyof?evening?primrose(Oenothera?sp.)Plant?Biotechnology?2(4):351-357.
14.Chen?PY,Wang?CK,Soong?SC,To?KY(2003)Complete?sequence?ofthe?binary?vector?pBI121?and?its?application?in?cloning?T-DNA?insertionfrom?transgenic?plants.Molecular?Breeding?11:287-293.
15.Hoekema?A,Hirsch?PR,Hooykaas?PJJ,Schilperoort?RA(1983)Abinary?plant?vetor?strategy?based?on?separation?of?vir-and?T-region?of?theAgrobacterium?tumefaciens?Ti-plasmid.Nature?303:179-180.
The IB051489-sequence table
SEQUENCE?LISTING
<110〉Inst. of Genetics and Development Biology, CAS
<120〉have the mosaic gene and the application thereof of Δ 6 fatty acid dehydrogenase functions
<130>IB051489
<160>13
<170>PatentIn?version?3.1
<210>1
<211>1347
<212>DNA
<213〉artificial sequence
<400>1
atggctaatg?caatcaagaa?gtacatgaca?gttgaggagc?taaaagtgca?taacaagcca 60
gaggatttgt?ggatctctat?tcagggtaag?gtttacaatg?tcactgattg?gaaaaaggaa 120
cacccaggtg?gggatagctc?tctcctgaat?ctaggtggtc?aagatgtcac?agatgcattc 180
attgcttatc?atccaggtac?tgcttggcaa?tatcttgaca?ggttctttac?tgggtattat 240
ctcaaagatt?tcaatgtctc?agatgtatcc?aaagattata?gaaaacttgc?atctgagttt 300
accaaaatgg?gtctttttgc?aaagaaaggg?catggtgttt?tctactcctt?ttgtcttggg 360
gcattcttgt?ttgctgtttg?tgtttatggt?gttttgtatt?ctcaaagttt?gtttgtgcat 420
ttgtgttgtg?gtgggatttt?ggggttttta?tggatgcaaa?gtggttatgc?tggtcacgat 480
tctgggcatt?atcagacaat?gtctactcct?ttttatacca?atttggctca?aattcttact 540
ggaaattgcc?ttagtggtat?tagtatggct?tggtggaaat?ggacccacaa?tgctcaccac 600
gttgctgtta?atagtattga?ccatgaccct?gatcttcagt?acatgccatt?ttttgtcctc 660
tctcccaaat?tgttcaatgg?cataacttct?cgcttttatg?ggaggaagtt?ggagtttgat 720
gcttttgcta?ggttcatggt?aagttatcag?cattggacat?tttatccggt?gatgattttt 780
gcacgatttt?atatgtttgt?gcccacgttt?tttatgttgc?tttcaaagaa?aaaagtaccc 840
aacagacctt?tgaatatagc?gggaattatt?gtgttctgga?tttggtttcc?tcttcttgtt 900
tcatgccttc?ccaattggac?tgagaggatg?atgtttgtgc?tagtgagctt?tacagttact 960
tcaattcaac?acgttacatt?ttgtttgaat?cactactcgg?ctgataatta?tatgggacat 1020
cctactggga?acgattggtt?tgagaagcag?acaagtggga?ctttggacat?ttcgtgcccg 1080
tcttggatgg?attggtttca?tggtgggctg?caattccaaa?ttgagcatca?tttgttccct 1140
cgattgcctc?gatgccagct?taggacggtc?tctccttttg?cgatggagct?atgcaagaag 1200
cacaatttgc?cttataggag?tttgtccttt?ttggaggcca?atgtcgcgac?cattatgacg 1260
ttgaggactg?cagccctgca?agcgcgcgac?ttgtccaacc?cggttccgaa?gaacttgctc 1320
tgggaagctg?tcacctgccc?ggggtga 1347
<210>2
<211>1347
<212>DNA
<213〉artificial sequence
<400>2
atggctaatg?caatcaagaa?gtacatgaca?gttgaggagc?taaaagtgca?taacaagcca 60
gaggatttgt?ggatctctat?tcagggtaag?gtttacaatg?tcactgattg?gaaaaaggaa 120
cacccaggtg?gggatagctc?tctcctgaat?ctaggtggtc?aagatgtcac?agatgcattc 180
attgcttatc?atccaggtac?tgcttggcaa?tatcttgaca?ggttctttac?tgggtattat 240
ctcaaagatt?tcaatgtctc?agatgtatcc?aaagattata?gaaaacttgc?atctgagttt 300
accaaaatgg?gtctttttgc?aaagaaaggg?catggtgttt?tctactcctt?ttgtcttggg 360
gcattcttgt?ttgctgtttg?tgtttatggt?gttttgtatt?ctcaaagttt?gtttgtgcat 420
ttgtgttgtg?gtgggatttt?ggggttttta?tggatgcaaa?gtggttatgc?tggtcacgat 480
tctgggcatt?atcagacaat?gtctactcct?ttttatacca?atttggctca?aattcttact 540
ggaaattgcc?ttagtggtat?tagtatggct?tggtggaaat?ggacccacaa?tgctcaccac 600
gttgctgtta?atagtattga?ccatgaccct?gatcttcagt?acatgccatt?ttttgtcctc 660
tctcccaaat?tgttcaatgg?cataacttct?cgcttttatg?ggaggaagtt?ggagtttgat 720
gcttttgcta?ggttcatggt?aagttatcag?cattggacat?tttatccggt?gatgattttt 780
gcacgatttt?atatgtttgt?gcccacgttt?tttatgttgc?tttcaaagaa?aaaagtaccc 840
aacagacctt?tgaatatagc?gggaattatt?gtgttctgga?tttggtttcc?tcttcttgtt 900
tcatgccttc?ccaattggac?tgagaggatg?atgtttgtgc?tagtgagctt?tacagttact 960
tcaattcaac?acgttacatt?ttgtttgaat?cactactcgg?ctgataatta?tatgggacat 1020
cctactggga?acgattggtt?tgagaagcag?acaagtggga?ctttggacat?ttcgtgcccg 1080
tcttggatgg?attggtttca?tggtgggctg?caattccaaa?ttgagcatca?tttgttccca 1140
agattgcctc?gatgccagct?taggaaggtc?tctccttttg?tgaaagagct?ttgcaagaaa 1200
cacaatttgc?cttataggag?tttatcattt?tttgaggcca?atgttgcaac?cattaagacg 1260
ttgaggactg?ccgccttgca?agctcgcgac?ctatccaacc?ctatttcaaa?gaatttgcta 1320
tgggaagctg?tcaacaccta?tggctga 1347
<210>3
<211>227
<212>DNA
<213〉artificial sequence
<400>3
ttgagcatca?tttgttccct?cgattgcctc?gatgccagct?taggacggtc?tctccttttg 60
cgatggagct?atgcaagaag?cacaatttgc?cttataggag?tttgtccttt?ttggaggcca 120
atgtcgcgac?cattatgacg?ttgaggactg?cagccctgca?agcgcgcgac?ttgtccaacc 180
cggttccgaa?gaacttgctc?tgggaagctg?tcacctgccc?ggggtga 227
<210>4
<211>227
<212>DNA
<213〉artificial sequence
<400>4
ttgagcatca?tttgttccca?agattgcctc?gatgccagct?taggaaggtc?tctccttttg 60
tgaaagagct?ttgcaagaaa?cacaatttgc?cttataggag?tttatcattt?tttgaggcca 120
atgttgcaac?cattaagacg?ttgaggactg?ccgccttgca?agctcgcgac?ctatccaacc 180
ctatttcaaa?gaatttgcta?tgggaagctg?tcaacaccta?tggctga 227
<210>5
<211>1139
<212>DNA
<213〉artificial sequence
<400>5
atggctaatg?caatcaagaa?gtacatgaca?gttgaggagc?taaaagtgca?taacaagcca 60
gaggatttgt?ggatctctat?tcagggtaag?gtttacaatg?tcactgattg?gaaaaaggaa 120
cacccaggtg?gggatagctc?tctcctgaat?ctaggtggtc?aagatgtcac?agatgcattc 180
attgcttatc?atccaggtac?tgcttggcaa?tatcttgaca?ggttctttac?tgggtattat 240
ctcaaagatt?tcaatgtctc?agatgtatcc?aaagattata?gaaaacttgc?atctgagttt 300
accaaaatgg?gtctttttgc?aaagaaaggg?catggtgttt?tctactcctt?ttgtcttggg 360
gcattcttgt?ttgctgtttg?tgtttatggt?gttttgtatt?ctcaaagttt?gtttgtgcat 420
ttgtgttgtg?gtgggatttt?ggggttttta?tggatgcaaa?gtggttatgc?tggtcacgat 480
tctgggcatt?atcagacaat?gtctactcct?ttttatacca?atttggctca?aattcttact 540
ggaaattgcc?ttagtggtat?tagtatggct?tggtggaaat?ggacccacaa?tgctcaccac 600
gttgctgtta?atagtattga?ccatgaccct?gatcttcagt?acatgccatt?ttttgtcctc 660
tctcccaaat?tgttcaatgg?cataacttct?cgcttttatg?ggaggaagtt?ggagtttgat 720
gcttttgcta?ggttcatggt?aagttatcag?cattggacat?tttatccggt?gatgattttt 780
gcacgatttt?atatgtttgt?gcccacgttt?tttatgttgc?tttcaaagaa?aaaagtaccc 840
aacagacctt?tgaatatagc?gggaattatt?gtgttctgga?tttggtttcc?tcttcttgtt 900
tcatgccttc?ccaattggac?tgagaggatg?atgtttgtgc?tagtgagctt?tacagttact 960
tcaattcaac?acgttacatt?ttgtttgaat?cactactcgg?ctgataatta?tatgggacat 1020
cctactggga?acgattggtt?tgagaagcag?acaagtggga?ctttggacat?ttcgtgcccg 1080
tcttggatgg?attggtttca?tggtgggctg?caattccaaa?ttgagcatca?tttgttccc 1139
<210>6
<211>448
<212>PRT
<213〉artificial sequence
<400>6
Met?Ala?Asn?Ala?Ile?Lys?Lys?Tyr?Met?Thr?Val?Glu?Glu?Leu?Lys?Val
1 5 10 15
His?Asn?Lys?Pro?Glu?Asp?Leu?Trp?Ile?Ser?Ile?Gln?Gly?Lys?Val?Tyr
20 25 30
Asn?Val?Thr?Asp?Trp?Lys?Lys?Glu?His?Pro?Gly?Gly?Asp?Ser?Ser?Leu
35 40 45
Leu?Asn?Leu?Gly?Gly?Gln?Asp?Val?Thr?Asp?Ala?Phe?Ile?Ala?Tyr?His
50 55 60
Pro?Gly?Thr?Ala?Trp?Gln?Tyr?Leu?Asp?Arg?Phe?Phe?Thr?Gly?Tyr?Tyr
65 70 75 80
Leu?Lys?Asp?Phe?Asn?Val?Ser?Asp?Val?Ser?Lys?Asp?Tyr?Arg?Lys?Leu
85 90 95
Ala?Ser?Glu?Phe?Thr?Lys?Met?Gly?Leu?Phe?Ala?Lys?Lys?Gly?His?Gly
100 105 110
Val?Phe?Tyr?Ser?Phe?Cys?Leu?Gly?Ala?Phe?Leu?Phe?Ala?Val?Cys?Val
115 120 125
Tyr?Gly?Val?Leu?Tyr?Ser?Gln?Ser?Leu?Phe?Val?His?Leu?Cys?Cys?Gly
130 135 140
Gly?Ile?Leu?Gly?Phe?Leu?Trp?Met?Gln?Ser?Gly?Tyr?Ala?Gly?His?Asp
145 150 155 160
Ser?Gly?His?Tyr?Gln?Thr?Met?Ser?Thr?Pro?Phe?Tyr?Thr?Asn?Leu?Ala
165 170 175
Gln?Ile?Leu?Thr?Gly?Asn?Cys?Leu?Ser?Gly?Ile?Ser?Met?Ala?Trp?Trp
180 185 190
Lys?Trp?Thr?His?Asn?Ala?His?His?Val?Ala?Val?Asn?Ser?Ile?Asp?His
195 200 205
Asp?Pro?Asp?Leu?Gln?Tyr?Met?Pro?Phe?Phe?Val?Leu?Ser?Pro?Lys?Leu
210 215 220
Phe?Asn?Gly?Ile?Thr?Ser?Arg?Phe?Tyr?Gly?Arg?Lys?Leu?Glu?Phe?Asp
225 230 235 240
Ala?Phe?Ala?Arg?Phe?Met?Val?Ser?Tyr?Gln?His?Trp?Thr?Phe?Tyr?Pro
245 250 255
Val?Met?Ile?Phe?Ala?Arg?Phe?Tyr?Met?Phe?Val?Pro?Thr?Phe?Phe?Met
260 265 270
Leu?Leu?Ser?Lys?Lys?Lys?Val?Pro?Asn?Arg?Pro?Leu?Asn?Ile?Ala?Gly
275 280 285
Ile?Ile?Val?Phe?Trp?Ile?Trp?Phe?Pro?Leu?Leu?Val?Ser?Cys?Leu?Pro
290 295 300
Asn?Trp?Thr?Glu?Arg?Met?Met?Phe?Val?Leu?Val?Ser?Phe?Thr?Val?Thr
305 310 315 320
Ser?Ile?Gln?His?Val?Thr?Phe?Cys?Leu?Asn?His?Tyr?Ser?Ala?Asp?Asn
325 330 335
Tyr?Met?Gly?His?Pro?Thr?Gly?Asn?Asp?Trp?Phe?Glu?Lys?Gln?Thr?Ser
340 345 350
Gly?Thr?Leu?Asp?Ile?Ser?Cys?Pro?Ser?Trp?Met?Asp?Trp?Phe?His?Gly
355 360 365
Gly?Leu?Gln?Phe?Gln?Ile?Glu?His?His?Leu?Phe?Pro?Arg?Leu?Pro?Arg
370 375 380
Cys?Gln?Leu?Arg?Thr?Val?Ser?Pro?Phe?Ala?Met?Glu?Leu?Cys?Lys?Lys
385 390 395 400
His?Asn?Leu?Pro?Tyr?Arg?Ser?Leu?Ser?Phe?Leu?Glu?Ala?Asn?Val?Ala
405 410 415
Thr?Ile?Met?Thr?Leu?Arg?Thr?Ala?Ala?Leu?Gln?Ala?Arg?Asp?Leu?Ser
420 425 430
Asn?Pro?Val?Pro?Lys?Asn?Leu?Leu?Trp?Glu?Ala?Val?Thr?Cys?Pro?Gly
435 440 445
<210>7
<211>448
<212>PRT
<213〉artificial sequence
<400>7
Met?Ala?Asn?Ala?Ile?Lys?Lys?Tyr?Met?Thr?Val?Glu?Glu?Leu?Lys?Val
1 5 10 15
His?Asn?Lys?Pro?Glu?Asp?Leu?Trp?Ile?Ser?Ile?Gln?Gly?Lys?Val?Tyr
20 25 30
Asn?Val?Thr?Asp?Trp?Lys?Lys?Glu?His?Pro?Gly?Gly?Asp?Ser?Ser?Leu
35 40 45
Leu?Asn?Leu?Gly?Gly?Gln?Asp?Val?Thr?Asp?Ala?Phe?Ile?Ala?Tyr?His
50 55 60
Pro?Gly?Thr?Ala?Trp?Gln?Tyr?Leu?Asp?Arg?Phe?Phe?Thr?Gly?Tyr?Tyr
65 70 75 80
Leu?Lys?Asp?Phe?Asn?Val?Ser?Asp?Val?Ser?Lys?Asp?Tyr?Arg?Lys?Leu
85 90 95
Ala?Ser?Glu?Phe?Thr?Lys?Met?Gly?Leu?Phe?Ala?Lys?Lys?Gly?His?Gly
100 105 110
Val?Phe?Tyr?Ser?Phe?Cys?Leu?Gly?Ala?Phe?Leu?Phe?Ala?Val?Cys?Val
115 120 125
Tyr?Gly?Val?Leu?Tyr?Ser?Gln?Ser?Leu?Phe?Val?His?Leu?Cys?Cys?Gly
130 135 140
Gly?Ile?Leu?Gly?Phe?Leu?Trp?Met?Gln?Ser?Gly?Tyr?Ala?Gly?His?Asp
145 150 155 160
Ser?Gly?His?Tyr?Gln?Thr?Met?Ser?Thr?Pro?Phe?Tyr?Thr?Asn?Leu?Ala
165 170 175
Gln?Ile?Leu?Thr?Gly?Asn?Cys?Leu?Ser?Gly?Ile?Ser?Met?Ala?Trp?Trp
180 185 190
Lys?Trp?Thr?His?Asn?Ala?His?His?Val?Ala?Val?Asn?Ser?Ile?Asp?His
195 200 205
Asp?Pro?Asp?Leu?Gln?Tyr?Met?Pro?Phe?Phe?Val?Leu?Ser?Pro?Lys?Leu
210 215 220
Phe?Asn?Gly?Ile?Thr?Ser?Arg?Phe?Tyr?Gly?Arg?Lys?Leu?Glu?Phe?Asp
225 230 235 240
Ala?Phe?Ala?Arg?Phe?Met?Val?Ser?Tyr?Gln?His?Trp?Thr?Phe?Tyr?Pro
245 250 255
Val?Met?Ile?Phe?Ala?Arg?Phe?Tyr?Met?Phe?Val?Pro?Thr?Phe?Phe?Met
260 265 270
Leu?Leu?Ser?Lys?Lys?Lys?Val?Pro?Asn?Arg?Pro?Leu?Asn?Ile?Ala?Gly
275 280 285
Ile?Ile?Val?Phe?Trp?Ile?Trp?Phe?Pro?Leu?Leu?Val?Ser?Cys?Leu?Pro
290 295 300
Asn?Trp?Thr?Glu?Arg?Met?Met?Phe?Val?Leu?Val?Ser?Phe?Thr?Val?Thr
305 310 315 320
Ser?Ile?Gln?His?Val?Thr?Phe?Cys?Leu?Asn?His?Tyr?Ser?Ala?Asp?Asn
325 330 335
Tyr?Met?Gly?His?Pro?Thr?Gly?Asn?Asp?Trp?Phe?Glu?Lys?Gln?Thr?Ser
340 345 350
Gly?Thr?Leu?Asp?Ile?Ser?Cys?Pro?Ser?Trp?Met?Asp?Trp?Phe?Hi?s?Gly
355 360 365
Gly?Leu?Gln?Phe?Gln?Ile?Glu?Hi?s?His?Leu?Phe?Pro?Arg?Leu?Pro?Arg
370 375 380
Cys?Gln?Leu?Arg?Lys?Val?Ser?Pro?Phe?Val?Lys?Glu?Leu?Cys?Lys?Lys
385 390 395 400
His?Asn?Leu?Pro?Tyr?Arg?Ser?Leu?Ser?Phe?Phe?Glu?Ala?Asn?Val?Ala
405 410 415
Thr?Ile?Lys?Thr?Leu?Arg?Thr?Ala?Ala?Leu?Gln?Ala?Arg?Asp?Leu?Ser
420 425 430
Asn?Pro?Ile?Ser?Lys?Asn?Leu?Leu?Trp?Glu?Ala?Val?Asn?Thr?Tyr?Gly
435 440 445
<210>8
<211>36
<212>DNA
<213〉artificial sequence
<400>8
ttgagcatca?tttgttccct?cgattgcctc?gatgcc 36
<210>9
<211>33
<212>DNA
<213〉artificial sequence
<400>9
gcggtctaga?tcaccccggg?caggtgacag?ctt 33
<210>10
<211>36
<212>DNA
<213〉artificial sequence
<400>10
ttgagcatca?tttgttccca?agattgcctc?gatgcc 36
<210>11
<211>36
<212>DNA
<213〉artificial sequence
<400>11
gcggtctaga?tcagccatag?gtgttgacag?cttccc 36
<210>12
<211>37
<212>DNA
<213〉artificial sequence
<400>12
cgcgaagctt?atggctaatg?caatcaagaa?gtacatg 37
<210>13
<211>24
<212>DNA
<213〉artificial sequence
<400>13
gggaacaaat?gatgctcaat?ttgg 24
Claims (12)
1. mosaic gene RnD6CA, its nucleotide sequence is shown in SEQ ID NO:1.
2. mosaic gene RnD6CB, its nucleotide sequence is shown in SEQ ID NO:2.
3. the mosaic gene RnD6CA encoded polypeptide of claim 1, its aminoacid sequence is shown in SEQID NO:6.
4. the mosaic gene RnD6CB encoded polypeptide of claim 2, its aminoacid sequence is shown in SEQID NO:7.
5. an expression vector is characterized in that comprising claim 1 or 2 described mosaic genes.
6. the expression vector of claim 5, it is Yeast expression carrier or plant expression vector.
7. the expression vector of claim 6, wherein said plant expression vector is selected from pBIN19, pBI121, or contain the evoked promoter of DRE and/or ABRE element and the plant expression vector that is used for the monocotyledons micropellet bombardment.
8. the expression vector of claim 5, it is characterized in that also comprising promotor, described promotor is selected from the promotor of cauliflower mosaic virus CaMV 35S, the promotor of ubiquitin (Ubiqutin), the promotor or the plant tissue position specific expression promoter of Actin muscle (Actin), and described promotor is used in combination separately or with other plant promoter.
9. host cell is characterized in that comprising the expression vector of claim 5, and described host cell is yeast cell or vegetable cell.
10. the host cell of claim 9, wherein said expression vector are that the mode by Ti-plasmids, Ri plasmid, plant viral vector, directly DNA conversion, microinjection or electroporation imports.
11. the host cell of claim 9, wherein said yeast cell are brewing yeast cell, described vegetable cell is the cell of tobacco, rape, Sunflower Receptacle, soybean, tomato, castor-oil plant, sesame or peanut.
12. the mosaic gene RnD6CA of claim 1 or the mosaic gene RnD6CB of claim 2 application in producing gamma-linolenic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100116085A CN100413969C (en) | 2005-04-21 | 2005-04-21 | Chimeric gene with delta 6 fatty acid dehydrogenase function and its use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100116085A CN100413969C (en) | 2005-04-21 | 2005-04-21 | Chimeric gene with delta 6 fatty acid dehydrogenase function and its use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1854298A CN1854298A (en) | 2006-11-01 |
CN100413969C true CN100413969C (en) | 2008-08-27 |
Family
ID=37194749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100116085A Expired - Fee Related CN100413969C (en) | 2005-04-21 | 2005-04-21 | Chimeric gene with delta 6 fatty acid dehydrogenase function and its use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100413969C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101353661B (en) * | 2007-07-25 | 2012-05-09 | 中国科学院遗传与发育生物学研究所 | Genes having delta 6 fatty acid dehydrogenase function and use thereof |
CN102839134B (en) * | 2012-09-24 | 2014-04-16 | 山东大学 | Yeast strain for producing alpha-linolenic acid, culture method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020170090A1 (en) * | 1997-02-18 | 2002-11-14 | Washington State University Research Foundation | Omega-3 fatty acid desaturase |
CN1570116A (en) * | 2004-05-13 | 2005-01-26 | 南开大学 | Rhizopus arrhizus delta[12]-fatty acid dehydrogenase nucleic acid sequence and its uses |
-
2005
- 2005-04-21 CN CNB2005100116085A patent/CN100413969C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020170090A1 (en) * | 1997-02-18 | 2002-11-14 | Washington State University Research Foundation | Omega-3 fatty acid desaturase |
CN1570116A (en) * | 2004-05-13 | 2005-01-26 | 南开大学 | Rhizopus arrhizus delta[12]-fatty acid dehydrogenase nucleic acid sequence and its uses |
Non-Patent Citations (1)
Title |
---|
$6_脂肪酸脱氢酶的分子生物学研究进展. 张琦等.生物工程学报,第20卷第3期. 2004 * |
Also Published As
Publication number | Publication date |
---|---|
CN1854298A (en) | 2006-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4511043B2 (en) | Increased stearate content in soybean oil by the expression of acyl-ACP thioesterase | |
CN1930293B (en) | Transgenic plants with reduced level of saturated fatty acid and methods for making them | |
CN101765658B (en) | Multizymes and use thereof in making polyunsaturated fatty acids | |
CN1871353B (en) | Fatty acid desaturases from primula | |
CN103068986B (en) | Reduce the saturated fatty acid content of plant seed | |
CN102782124B (en) | Novel delta9-elongase for production of polyunsaturated fatty acid-enriched oils | |
WO1998045458A1 (en) | An engineered seed protein having a higher percentage of essential amino acids | |
AU6761796A (en) | Compositions and method for modulation of gene expression in plants | |
CN101353661B (en) | Genes having delta 6 fatty acid dehydrogenase function and use thereof | |
CN100413969C (en) | Chimeric gene with delta 6 fatty acid dehydrogenase function and its use | |
CN104011062B (en) | The biomass of the transformation produced for biodiesel and bio-ethanol | |
CN106413389A (en) | Production of omega-3 long-chain polyunsaturated fatty acids in oilseed crops by a thraustochytrid PUFA synthase | |
CN110358776A (en) | A kind of Rhizoctonia solani Kuhn pathogenic related gene and its application | |
CN109402079B (en) | Application of polypeptide in improving content of plant ultra-long chain fatty acid | |
CN1738903A (en) | Immunization of fish with plant-expressed recombinant proteins | |
JP2010279297A (en) | Gene for increasing plant weight of plant and method for using the same | |
CA2082514A1 (en) | Production of cyclodextrins in transgenic plants | |
CN103276002B (en) | Oil body containing oil body protein and collagen fusion protein | |
CN101921784B (en) | Genes with functions of delta6 fatty acid desaturase and application thereof | |
US20210010014A1 (en) | Peanut with reduced allergen levels | |
JP2002505107A5 (en) | ||
CN102399758B (en) | Mutant gene mRnD6D having delta <6> fatty acid dehydrogenase functions and use thereof | |
CN103261419A (en) | Construct for regulating fertility of plant pollens and usage thereof | |
AU784958B2 (en) | Triacylglycerol lipases | |
CN101415822B (en) | Phosphopantetheinyl transferase from antibacterial |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080827 Termination date: 20140421 |